| Value | ₹2.49 Cr |
|---|
BSE filing, NSE: JUBLINGREA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Ingrevia Ltd: key numbers
- Share price
- ₹558.40
- Market cap
- ₹8,894 Cr
- Revenue (annual)
- ₹4,388 Cr
- Net profit (annual)
- ₹277.9 Cr
- P/E (TTM)
- 25.4×Sector 34.1×
- Promoter holding
- 45.22%+0.00% QoQ
- FII holding
- 6.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Ingrevia Ltd
All →Jubilant Ingrevia Other Announcement
Jubilant Ingrevia Limited filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing records the holdings of promoters, public shareholders and other categories.
Jubilant Ingrevia Earnings Call Transcript: Key Takeaways
Strong Q2 performance driven by volume growth across specialty chemicals and nutrition despite price softness in China.
Jubilant Ingrevia Management Change
Jubilant Ingrevia's Sr. Vice President & Head HR, Ms. Vinita Koul, resigned effective November 6, 2026. The departure is to pursue other interests.
Jubilant Ingrevia Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,394 Cr (+24% YoY), EBITDA ₹221 Cr (+51%, 16% margin), PAT ₹111 Cr (+61%). Pinnacle strategy continues; 40% ZettaOne stake (₹189.2 Cr) enters EDMS.
Jubilant Ingrevia Employee Stock Options
Jubilant Ingrevia board approved grant of 3,037 RSUs to eligible employees under its 2021 ESOP scheme. Vesting occurs at end of third year from grant date.
Jubilant Ingrevia Q2 FY27 Results: Net Profit ₹111.4 Cr, Up 60.3% YoY
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,394 Cr (+24.4% YoY) and net profit of ₹111.4 Cr (+60.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹111.4 Cr · +60.3% YoY
Other employee stock options announcements
All →Niva Bupa Health Insurance Company Employee Stock Options
Niva Bupa allotted 9,89,450 equity shares to employees on exercise of ESOP options under its 2020 and 2024 schemes. Paid-up capital rose to Rs. 18,50,63,41,530.
Meesho Employee Stock Options
Meesho allotted 21,43,590 equity shares to employees on exercise of ESOP 2024 options. No exercise price or consideration is disclosed in the filing.
Studds Accessories Employee Stock Options
Studds Accessories granted 1,30,000 ESOPs to eligible employees under its 2026 scheme at an exercise price of Rs 334.90. Options vest over time, converting to equity shares on exercise.
Poonawalla Fincorp Employee Stock Options
Poonawalla Fincorp allotted 30,773 equity shares under its employee stock option schemes on 31 October 2026. The shares rank pari passu with existing equity.
Eveready Industries India Employee Stock Options
Eveready Industries granted 48,000 stock options to eligible employees under its ESOP 2026 plan, approved by the NRC on 31 October 2026. The filing is an employee stock option grant intimation with no cash consideration stated.
Max Estates Employee Stock Options
Max Estates allotted 632 equity shares to an option holder under its ESOP Plan 2023. The allotment raises paid-up capital; no transaction price is stated.